Modern Healthcare Technology Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-3.00
-9.00
-18.00
-66.00
130.00
-27.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
71.00
1.00
68.00
33.00
-112.00
17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
151.00
78.00
139.00
51.00
123.00
63.00
Cash Flow from Investing Activities
-24.00
-12.00
-12.00
-87.00
-2.00
-19.00
Cash Flow from Financing Activities
-66.00
-70.00
-77.00
-78.00
-77.00
-48.00
Net Cash Inflow / Outflow
60.00
-4.00
50.00
-114.00
54.00
-7.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
10.00
-2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Modern Healthcare Technology Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-3.04
24.9271892098965
-27.00
-112.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
71.918
2.8100474377479
69.00
2459.32%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
151.088
49.6424897440563
102.00
204.35%
Cash Flow from Investing Activities
-24.703
-3.48102824424785
-21.00
-609.65%
Cash Flow from Financing Activities
-66.239
-21.0072487087653
-45.00
-215.31%
Net Cash Inflow / Outflow
60.158
25.1542127910431
35.00
139.16%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.012
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 92.09% vs -43.74% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
151.09
78.66
92.09%






